Evidence map›Paper›PMID 28612233›Full record

ReviewDrugs2017

Targeting the PGD

Maciej Kupczyk, Piotr Kuna

Open access · hybridAbstract readReview
In one paragraph

Review in Drugs, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 118 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Mechanisms and therapeutic strategies of asthma: from bench to bedside.Signal transduction and targeted therapy · 2026
    Review
  6. New insights into flavonoid binding to the thromboxane ABlood vessels, thrombosis & hemostasis · 2026
    Article
  7. Article
  8. Coactosin-Like Protein Reduces Prostaglandin DAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Mast cell-sensory neuron crosstalk in allergic diseases.The Journal of allergy and clinical immunology · 2024
    Review
  17. Review
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Maciej KupczykDepartment of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Kopcinskiego 22, 90-153, Lodz, Poland. Maciej.Kupczyk@umed.pl.ORCID http://orcid.org/0000-0002-5047-1279
Piotr KunaDepartment of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Kopcinskiego 22, 90-153, Lodz, Poland.
Karolinska Institutet · SEMedical University of Lodz · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostaglandin D

Indexed as

AnimalsAsthmaEosinophiliaHumansHypersensitivityInflammationInterleukinsProstaglandin D2Receptors, ImmunologicReceptors, ProstaglandinSignal TransductionInterleukinsProstaglandin D2prostaglandin D2 receptorprostanoid D receptor 1, humanReceptors, ImmunologicReceptors, Prostaglandin

Identifiers

PMID28612233
PMCPMC5529497
OpenAlexW2625270096

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.